Jefferies Group’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-8,600
Closed -$2.08M 1656
2020
Q1
$2.08M Buy
+8,600
New +$2.24M 0.02% 665
2018
Q1
Sell
-7,500
Closed -$1.17M 2455
2017
Q4
$1.17M Sell
7,500
-11,000
-59% -$1.73M 0.01% 1261
2017
Q3
$2.88M Buy
18,500
+2,500
+16% +$395K 0.02% 761
2017
Q2
$2.58M Buy
+16,000
New +$2.6M 0.02% 835
2015
Q3
Sell
-41,300
Closed -$2.65M 2626
2015
Q2
$2.65M Buy
+41,300
New +$2.86M 0.01% 781

Other funds holding IDXX

Jefferies Group's IDXX Position: Q3 2022 in Review

Jefferies Group opened a new position in Idexx Laboratories (IDXX) in Q3 2022: 6,500 shares worth $2.12M. The stake represents 0.02% of the portfolio and ranks #580 among its holdings. This is a return to the name: Jefferies Group previously reported a position in IDXX as recently as Q4 2021.

Jefferies Group first reported a position in IDXX in Q4 2013 and has held it in 26 quarters since. The position peaked at $7.28M in Q2 2017. 924 funds tracked by Wall St. Rank hold IDXX as of Q3 2022.

  • Jefferies Group held 6,500 shares of Idexx Laboratories worth $2.12M as of Q3 2022.
  • Idexx Laboratories was a new Jefferies Group position in Q3 2022.
  • Idexx Laboratories made up 0.02% of Jefferies Group's portfolio in Q3 2022, its #580 holding.
  • Jefferies Group first reported a position in Idexx Laboratories in Q4 2013 and has held it in 26 quarters since.
  • Jefferies Group's Idexx Laboratories position peaked at $7.28M in Q2 2017.
  • 924 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2022.

Based on Jefferies Group's 13F filing for Q3 2022, filed 14 Nov 2022.